Endocrinology, Diabetes & Metabolism Case Reports (Apr 2017)

Novel germline variant of TMEM127 gene in a patient with familial pheochromocytoma

  • Kohei Saitoh,
  • Takako Yonemoto,
  • Takeshi Usui,
  • Kazuhiro Takekoshi,
  • Makoto Suzuki,
  • Yoshiharu Nakashima,
  • Koji Yoshimura,
  • Rieko Kosugi,
  • Tatsuo Ogawa,
  • Tatsuhide Inoue

DOI
https://doi.org/10.1530/EDM-17-0014
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 5

Abstract

Read online

Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare tumours with a heterogeneous genetic background. Up to 40% of apparently sporadic PCC/PGL cases carry 1 of the 12 gene germline mutations conferring genetic susceptibility to PCC/PGL. Although the precise mechanisms are unclear, TMEM127 is one of the rare responsible genes for PCC/PGL. Here we report the case of a patient with familial PCC having a novel TMEM127 variant (c.119C > T, p.S40F). In silico prediction analysis to evaluate the functional significance of this variant suggested that it is a disease-causing variant. A PCC on the left side was considered to be the dominant lesion, and unilateral adrenalectomy was performed. The histopathologic findings were consistent with benign PCC. A loss of heterogeneity of the TMEM127 variant was detected in the surgically removed tumour.